How should Helicobacter pylori positive dyspeptic patients be managed?

Gut

Volumn 45, Issue SUPPL. 1, 1999, Pages

  Talley, N J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE;

AGE; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DISEASE ASSOCIATION; DYSPEPSIA; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; SINGLE BREATH NITROGEN TEST; STOMACH ULCER; TREATMENT OUTCOME;

EID: 0033057687     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.2008.i28     Document Type: Conference Paper

References (39)

1. 1 Talley NJ, Colin-Jones D, Koch KL, et al. Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 1991;4:145-60.
2. 2 Richter JE. Dyspepsia: organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol 1991;(suppl 182):11-16.
3. 3 Heikkinen M, Pikkarainen P, Takala J, et al. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995;30:519-23.
4. 4 Klauser AG, Voderholzer WA, Knesewitsch PA, et al. What is behind dyspepsia? Dig Dis Sci 1993;38:147-54.
5. 5 Talley NJ, Silverstein M, Agreus L, et al. AGA Technical Review: Evaluation of dyspepsia. Gastroenterology 1998; 114:582-95.
6. 6 American College of Physicians. Endoscopy in the evaluation of dyspepsia. Ann Intern Med 1985;102:266-9.
7. 7-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811-16.
8. 8 Axon ATR. Chronic dyspepsia: who needs endoscopy? Gastroenterology 1997;112:1376-80.
9. 9 Malfertheiner P, Megraud F, O'Morain C, et al. Current European concepts in the management of Helicobacter pylori infection the Maastricht Consensus report. Eur J Gastroenterol Hepatol 1997;9:1-2.
10. 10 Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Guidelines on the management of H pylori. J Gastroenterol Hepatol 1998;13:1-12.
11. 11 Hunt RH, Thompson ABR. Canadian Helicobacter pylori consensus conference. Can J Gastroenterol 1998;12:31-41
12. 12 Howden CW. For what conditions is there evidence-based justification for treatment of Helicobacter pylori infection? Gastroenterology 1997;113(suppl 6):S107-12
13. 13 McColl KEL, El-Nujumi A, Murray L, et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997;40:302-6.
14. 14 Mendall MA, Jazrawi RP, Marrero JM, et al. Scrology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut 1995;36:330-3.
15. 15 Patel P, Khulusi S Mendall MA, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995;346:1315-18.
16. 16 Vaira D, Stanghellini V, Menegatti M, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? Endoscopy 1997;29:595-601.
17. 17 Fraser AG, Ali MR, McCullogh S, et al. Diagnostic tests for Helicobacter pylori - can they select patients for endoscopy? NZ Med J 1996;109:95-8.
18. 18 Collins JSA, Ramford KB, Sloan JM, et al. Screening for Helicobacter pylori antibody could reduce endoscopy workload in young dyspeptic patients. Eur J Gastroenterol Hepatol 1992;4:991-3.
19. 19 Heikkinen M, Hanatuinen E, Mayo K, et al. Usefulness of anti-Helicobacter pylori and anti-cagA antibodies in the selection of patients for gastroscopy. Am J Gastroenterol 1997;92:2225-9.
20. 20 Mendall MA, Goggin PM, Marrero JM, et al. Role of Helicobacter pylori serology in screening prior to endoscopy. Eur J Gastroenterol Hepatol 1992;4:713-17.
21. 14C-urea breath test in determining Helicobacter pylori status and predicting ulcer disease in dyspeptic patients. Am J Gastroenterol 1998;93: 20-5.
22. 22 Axon A, Forman D. Helicobacter gastroduodenitis: a serious infectious disease. BMJ 1997;314:1430-31.
23. 23 Williams B, Luckas M, Ellingham JH, et al. Do young patients with dyspepsia need investigation? Lancet 1988;ii: 1349-51.
24. 24 Christie J, Shepherd NA, Codling BW, et al. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 1997;41:513-17.
25. 25 Heaney A, Collins JSA, Watson RGP, et al. A prospective randomised trial for a test and treat policy versus gastroscopy in young H pylori positive dyspeptic patients [abstract]. Gut 1998;42(suppl 1):A17.
26. 26 Jones RH, Tait CL, Sladen G, et al. A Helicobacter test and treat strategy: costs and outcomes in a randomised controlled trial in primary care [abstract]. Gut 1998;42(suppl 1):A81.
27. 27 Duggan A, Elliott C, Logan RPH, et al. Does near patient II. pylori testing in primary care reduce referral for endoscopy? Results from a randomised trial [abstract]. Gut 1998;42(suppl 1):A82.
28. 28 Lassen AT, Pedersen FM, Bytzer P, et al. H. pylori test and treat or prompt endoscopy for dyspeptic patients in primary care. A randomized controlled trial of two management strategies: one year follow-up [abstract]. Gastroenterology 1998;114:A196.
29. 29 Agreus L, Talley N. Challenges in managing dyspepsia in general practice. BMJ 1997;315:1284-8.
30. 30 Xia H H-X, Talley NJ, Keane CT, et al. Recurrence of Helicobacter pylori infection after successful eradication: nature, possible causes and potential preventive strategies. Dig Dis Sci 1997;42:1821-34.
31. 31 Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gantroenterology 1994; 106:1174-83.
32. 32 Veldhuyzen van Zanten S, Talley NJ. Should antibiotic treatment of Helicobacter positive patients within non-ulcer dyspepsia now be recommended? Eur J Gastroenterol Hepatol 1998;10:367-70.
33. 33 McColl KEL, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339: 1869-74.
34. 34 Talley NJ, Janssens J, Lauritsen K, et al. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind controlled trial with 12 months' follow up. BMJ 1999;318:833-7.
35. 35 Blum AL, Talley NJ, O'Morain C, et al. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998;339:1875-81.
36. 36 Koelz HR, Arnold R, Stolte M, et al. Treatment of Helicobacter pylori (HP) does not improve symptoms of functional dyspepsia (FD) [abstract]. Gastroenterology 1998;114:A182.
37. 37 Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
38. 38 Talley NJ, Janssens J, Lauritsen K, et al. No increase of reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial [abstract]. Gastroenterology 1998;114:A1250.
39. 39 Parsonnet J, Harris RA, Hack HM, et al. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996;348:150-4.